Meiragtx, Llc
Clinical trials sponsored by Meiragtx, Llc, explained in plain language.
-
One-Shot gene injection aims to fix Radiation-Damaged saliva glands
Disease control OngoingThis early-stage study is testing the safety of a single gene therapy injection for people with severe, permanent dry mouth caused by radiation treatment for head and neck cancer. Researchers are delivering a modified virus carrying a gene (AQP1) directly into one parotid saliva …
Phase: PHASE1 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Gene therapy trial tracks Long-Term safety for Radiation-Induced dry mouth
Disease control ENROLLING_BY_INVITATIONThis study is following patients for up to five years to check the long-term safety and effectiveness of an experimental gene therapy for severe, persistent dry mouth. The therapy involves injecting a modified virus into the salivary glands to help them produce more saliva. It is…
Phase: PHASE2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC